Bleakley Financial Group, LLC Orasure Technologies Inc Transaction History

Bleakley Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.2 - $6.18 $81,295 - $119,620	-19,356 Reduced 55.62%	15,444 $65.8 Million
Q1 2024 May 08, 2024	SELL	$6.08 - $8.28 $24,836 - $33,823	-4,085 Reduced 10.51%	34,800 $214 Million
Q4 2023 Jan 25, 2024	SELL	$5.13 - $8.35 $5,904 - $9,610	-1,151 Reduced 2.87%	38,885 $319 Million
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $104,671 - $164,381	23,789 Added 146.42%	40,036 $237 Million
Q2 2023 Aug 14, 2023	SELL	$4.88 - $7.39 $3,079 - $4,663	-631 Reduced 3.74%	16,247 $81.4 Million
Q1 2023 May 12, 2023	BUY	$4.66 - $6.52 $14,301 - $20,009	3,069 Added 22.22%	16,878 $102 Million
Q4 2022 Feb 07, 2023	BUY	$3.7 - $5.29 $51,093 - $73,049	13,809 New	13,809 $66.6 Million

202

65.4M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $273M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.